Julie Gurbacki alias Dr. Bloodwork Bucks

Julie Gurbacki is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Hormonal imbalances (ex. thyroid, menstrual cycle irregularities, menopause, men's hormones, low testosterone).

Hormonal imbalances (ex. thyroid, menstrual cycle irregularities, menopause, men's hormones, low testosterone)

Supports

The influencer’s fragmentary claim appears to be that “hormonal imbalances” (including thyroid disorders, menstrual irregularities, menopause, and low testosterone in men) are clinically important. High‑quality evidence supports that clinically significant hormonal disorders do cause health problems and warrant diagnosis and targeted management. Thyroid disease guidelines explicitly describe adverse consequences of both hypothyroidism and hyperthyroidism, including increased cardiovascular morbidity and mortality, dyslipidemia, and osteoporosis, showing that thyroid hormone imbalance has major health effects when untreated. Major endocrine and urology guidelines on male hypogonadism (testosterone deficiency) state that low testosterone is associated with reduced quality of life and multiple complications (sexual dysfunction, loss of muscle and bone mass, anemia) and increased cardiovascular risk, and that appropriately diagnosed hypogonadism should be treated to restore physiological androgen‑dependent functions and improve symptoms. Systematic reviews and guidelines on conditions like PCOS, infertility, and metabolic dysregulation consistently describe hormonal imbalance (often involving reproductive hormones and insulin resistance) as central to the pathophysiology, and RCT‑based systematic reviews show that targeted interventions (e.g., probiotics/synbiotics in PCOS, lifestyle and metabolic therapies) can improve hormonal parameters and clinical outcomes. Modern clinical practice guidelines emphasize that menopause and other female hormonal transitions involve predictable hormonal changes that can cause bothersome symptoms, and evidence‑based therapies (e.g., menopausal hormone therapy under proper risk assessment) can improve quality of life, though these are individualized decisions. Overall, high‑quality evidence strongly supports the idea that discrete, well‑defined hormonal disorders (thyroid disease, PCOS, male hypogonadism, menopausal symptom complexes) are real, measurable, and clinically important, and that guideline‑directed evaluation and treatment can improve outcomes.

Contradicts

The claim, as stated, is extremely vague and implies that generic “hormonal imbalances” across thyroid, menstrual cycle, menopause, and men’s hormones are a unified, catch‑all explanation for health problems, which is not supported by high‑quality evidence. Guidelines on thyroid disease and male hypogonadism emphasize that diagnosis requires objective biochemical abnormalities plus compatible symptoms; they explicitly warn that symptoms are nonspecific and that treating people on the basis of vague complaints or modest hormone variations without clear diagnostic criteria is not evidence‑based. Major endocrine society guidelines caution against routine testosterone therapy in all older men with low levels and no clear symptoms or indications, reflecting that the relationship between hormone level and benefit/risk is nuanced and not simply “any hormonal imbalance should be corrected.” Evidence on PCOS, infertility, and metabolic endocrine disorders shows that while hormone abnormalities are central, they are typically part of complex multifactorial conditions involving genetics, lifestyle, and environmental exposures; high‑quality studies do not support the simplistic notion that any perceived hormone fluctuation or normal life stage (e.g., menopause) is itself a pathologic imbalance requiring correction. Systematic reviews of environmental toxins and endocrine‑disrupting chemicals show associations between exposures, hormonal changes, and specific outcomes, but they also highlight heterogeneity, moderate strength of evidence, and the need for better causal data; these do not justify broad claims that unspecified “hormonal imbalances” explain a wide array of symptoms in the general population. In summary, what is not supported is the influencer‑style framing that loosely defined hormonal imbalances across many systems are a pervasive, primary cause of common symptoms without rigorous diagnostic work‑up, or that they should uniformly be “fixed” rather than interpreted in clinical context.

Mainstream view

Mainstream medical and scientific consensus is that: 1) Hormones are critical regulators of physiology, and well‑defined endocrine disorders (such as hypothyroidism, hyperthyroidism, PCOS, male hypogonadism, and the hormonal changes of menopause) have clear diagnostic criteria, established pathophysiology, and evidence‑based treatments when they cause significant symptoms or health risks. 2) Diagnosis of hormonal disorders requires a combination of history, physical examination, and validated laboratory thresholds, often repeated and interpreted in context; isolated symptoms or minor lab variations in otherwise healthy people are not automatically treated as “hormonal imbalances.” 3) For male hypogonadism, thyroid disease, PCOS, and menopause‑related symptoms, major guidelines support targeted therapy when benefits outweigh risks, but do not endorse broad screening and treatment of asymptomatic or minimally symptomatic individuals solely on the basis of hormone levels. 4) Menopause and menstrual cycle variations are normal physiological states that can be associated with bothersome symptoms; they

Papers listed for this claim:[1][2][3][4]

In their own wordsView sourceArchived copy

“Hormonal imbalances (ex. thyroid, menstrual cycle irregularities, menopause, men's hormones, low testosterone)”

Rule: Neb. Rev. Stat. § 38-805(1)

See every doc bro who says they can treat or advise on Hormone imbalance and replacement

Julie Gurbacki is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Autoimmune conditions.

Autoimmune conditions

Supports

There is some very preliminary evidence that chiropractic spinal manipulation can transiently change immune-related biomarkers such as cytokines (e.g., IL-6, TNF-α) in adults with spinal pain, suggesting a possible modulation of inflammatory pathways, but these studies do not involve patients with specific autoimmune diseases and do not demonstrate clinical benefit on autoimmune disease activity or outcomes. A pilot randomized trial is underway to examine effects of thoracic spinal manipulation on cytokine levels in patients with relapsing–remitting multiple sclerosis, but this is an exploratory biomarker study and not evidence of disease control or remission in autoimmune disease. Overall, existing randomized trials and mechanistic studies suggest at most short-term changes in immune or stress biomarkers, not disease-modifying effects in autoimmune conditions.

Contradicts

A recent systematic review of spinal manipulative therapy and immune or infectious disease outcomes found no clinical studies demonstrating that spinal manipulation prevents infectious disease or improves disease-specific outcomes; the authors concluded there is no clinical evidence to support or refute claims that spinal manipulation meaningfully changes immune system outcomes, and that the clinical relevance of short-term biomarker changes is unknown. A united position statement from chiropractic researchers similarly concluded that no valid clinical evidence shows chiropractic care can enhance immune function or prevent infections, and emphasized that claims of immune enhancement are unsubstantiated. Major, contemporary autoimmune disease guidelines in rheumatology, gastroenterology, neurology, and related specialties focus on immunosuppressive or immunomodulatory drugs (e.g., corticosteroids, disease-modifying antirheumatic drugs, biologics, targeted synthetic agents), adjunctive nutritional care, and appropriate vaccination, and do not recommend chiropractic or spinal manipulation as a disease-modifying treatment for autoimmune conditions. Guidelines for systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, and other autoimmune diseases specify pharmacologic, nutritional, and rehabilitative strategies but do not list chiropractic care as a therapy for controlling autoimmune disease activity, preventing flares, or modifying long-term outcomes. Existing evidence for chiropractic care in comorbid neurological conditions (e.g., Alzheimer’s or Parkinson’s disease) is limited to small pilot trials assessing EEG changes and does not involve autoimmune pathophysiology or clinical autoimmune endpoints. Overall, claims that chiropractic treatment can treat or control autoimmune diseases themselves are not supported by randomized clinical trials, systematic reviews, or major guidelines.

Mainstream view

The mainstream medical and scientific view is that autoimmune diseases are driven by dysregulated immune responses requiring disease-specific, evidence-based immunomodulatory therapies (such as corticosteroids, conventional and biologic disease-modifying antirheumatic drugs, targeted synthetic agents, and sometimes stem cell or other advanced therapies), along with supportive measures including clinical nutrition, rehabilitation, and vaccination. Clinical practice guidelines across rheumatology, gastroenterology, neurology, and related fields consistently recommend pharmacologic immunosuppression or immunomodulation as the mainstay of treatment and do not recommend chiropractic or spinal manipulation as a primary or disease-modifying therapy for autoimmune conditions. Nonpharmacologic interventions (exercise, physical therapy, psychosocial support) may be recommended for symptom relief and function, but chiropractic care is regarded, at most, as an optional musculoskeletal or pain-management modality without evidence that it alters autoimmune disease activity, prevents progression, or replaces standard immunosuppressive treatment. Mainstream experts and guideline panels therefore consider chiropractic adjustments inappropriate as a stand-alone treatment for autoimmune diseases and emphasize maintaining or initiating guideline-directed immunomodulatory therapy and other standard care measures.

Papers listed for this claim:[5][6][7][8][9][10][11][12][13][14][15][16]

In their own wordsView sourceArchived copy

“Autoimmune conditions”

Rule: Neb. Rev. Stat. § 38-805(1)

See every doc bro who says they can treat or advise on Autoimmune disease

Julie Gurbacki is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Chronic fatigue and low energy.

Chronic fatigue and low energy

Supports

High-quality evidence specifically testing chiropractic treatment for chronic fatigue syndrome or chronic low energy is essentially absent. Available academic and guideline literature focuses on other interventions (cognitive‑behavioural therapy, graded or paced physical activity, pharmacologic or nutritional approaches, and symptom management) rather than chiropractic spinal manipulation. Large randomized trials and systematic reviews show that various non‑chiropractic interventions (e.g., CBT, physical activity programs, acupuncture, herbal formulas, supplements) can produce modest improvements in fatigue and function in chronic fatigue syndrome or chronic conditions associated with fatigue, but these do not involve chiropractic care. Some small, uncontrolled chiropractic case reports and prospective series suggest possible improvement in quality of life or fatigue in individual patients with chronic fatigue, but these are anecdotal, lack control groups, and are not high‑quality evidence; they therefore provide only hypothesis‑generating support rather than robust confirmation. Overall, there is no systematic review, major guideline, or adequately powered RCT demonstrating that chiropractic treatment reliably improves chronic fatigue or low energy in the general population.

Contradicts

Major clinical guidelines for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) emphasize diagnosis, energy management/pacing, individualized activity plans, psychological support, and management of co‑morbidities; they do not recommend chiropractic manipulation as a standard or evidence‑based treatment for chronic fatigue or low energy. Systematic reviews of randomized trials in ME/CFS and in fatigue associated with chronic conditions conclude that, although some interventions such as CBT, graded or structured physical activity, and certain complementary approaches may have modest benefit, there is no single definitive, reproducible cure and many interventions show limited or inconsistent effects, highlighting the overall weakness of the evidence base. The absence of chiropractic in these reviews and guidelines indicates a lack of supportive data rather than active recommendation. Moreover, the concept of treating chronic fatigue or low energy by spinal manipulation is not grounded in the pathophysiology described in mainstream ME/CFS and fatigue research, which instead emphasizes neuroimmune, autonomic, metabolic, and psychosocial factors. Thus, the influencer’s suggestion that chiropractic treatment is an evidence‑based or primary therapy for chronic fatigue is contradicted by the current guideline‑driven and trial‑based literature, which either does not mention it or implicitly deprioritizes it in favor of better‑studied approaches.

Mainstream view

The mainstream medical position is that chronic fatigue and ME/CFS are complex, multifactorial conditions with unclear etiology and no single proven curative treatment. Management is typically multimodal and may include: careful diagnosis and exclusion of other medical causes; education about the illness; activity and energy management (often pacing rather than aggressive graded exercise); addressing sleep, pain, mood, and autonomic symptoms; and, in some cases, structured psychological or physical activity interventions such as CBT or tailored exercise programs. Nutritional or complementary interventions (e.g., CoQ10 plus NADH, herbal formulas, acupuncture, moxibustion) have emerging but still limited evidence and are considered experimental or adjunctive rather than definitive therapies. Chiropractic spinal manipulation is not a standard or guideline‑recommended treatment for chronic fatigue or low energy, and high‑quality evidence supporting its efficacy is lacking; at most, it may be used for co‑existing musculoskeletal pain, not as a primary therapy for fatigue itself. Overall, mainstream practice treats chiropractic for chronic fatigue as unproven and secondary, with priority given to interventions supported by randomized trials and guidelines.

Papers listed for this claim:[5][6][7][9][8][10][11][12][17][18][19][20]

In their own wordsView sourceArchived copy

“Chronic fatigue and low energy”

Rule: Neb. Rev. Stat. § 38-805(1)

See every doc bro who says they can treat or advise on Chronic fatigue and fibromyalgia

Julie Gurbacki is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Anxiety, depression, and mood swings.

Anxiety, depression, and mood swings

Supports

High-quality evidence directly testing chiropractic treatment for anxiety is limited but includes small randomized controlled trials and low- to moderate-quality systematic reviews of manual therapy more broadly. One early randomized controlled trial found that thoracic spine chiropractic adjustments reduced blood pressure and state anxiety in hypertensive patients compared with placebo and no-treatment control, with significant blood pressure reductions and anxiety decreases in the active group, though anxiety also decreased in the control group, suggesting non-specific effects. A broader systematic review of manual therapy modalities and depression reported that manipulative therapies, including chiropractic manipulation, were associated with significant reductions in depressive symptoms in most included studies (5 of 6 chiropractic studies showed benefit), but the overall evidence was graded only as moderate (“B” rating) and emphasized a complementary, not primary, role for manual therapy. Additional small studies and case series (e.g., upper cervical chiropractic care case series showing decreased GAD-7 and PHQ-9 scores; various case reports of reduced anxiety or depressive symptoms under chiropractic management) suggest possible symptom improvements, but these are uncontrolled, small, and at high risk of bias. Overall, the best available evidence suggests that chiropractic or other manual therapies may reduce anxiety or depressive symptom scores in some patients, particularly when coexisting with pain, but this support is based on small trials and complementary-therapy systematic reviews rather than large, definitive RCTs or major guidelines.

Contradicts

There is a substantial lack of high-quality, large randomized trials or major psychiatric guidelines endorsing chiropractic care as a primary treatment for anxiety, depression, or mood disorders. The randomized trial on blood pressure and anxiety showed decreased anxiety in both active and control (no-treatment) conditions, indicating that improvements may be due to placebo, regression to the mean, or non-specific factors rather than a specific chiropractic effect. Case reports and small case series, while often positive, have no control groups, small sample sizes, and high risk of bias, so they cannot establish causality or generalizability. A systematic review and meta-analysis of manual osteopathic interventions on anxiety, depression, and stress found no significant effects on anxiety in pooled analyses, underscoring that not all manual therapies meaningfully change anxiety outcomes and suggesting that effects may be inconsistent or clinically small. Clinical commentary and narrative reviews within chiropractic literature acknowledge that evidence for chiropractic management of anxiety and depressive disorders is limited and that existing trials are few and conflicting. Major mental health treatment guidelines (for anxiety disorders and depressive disorders) prioritize evidence-based psychological therapies (such as CBT), pharmacotherapy (e.g., SSRIs, SNRIs), and other established interventions, and do not list chiropractic manipulation as a recommended treatment; available evidence therefore weakly supports using chiropractic care as a direct treatment for these psychiatric conditions, and any claim of robust efficacy over standard care is contradicted by the current evidence base.

Mainstream view

The mainstream medical and psychiatric position is that chiropractic care is not an established or guideline-recommended primary treatment for anxiety, depression, or mood swings. Chiropractic and other manual therapies may play a complementary role for some patients, particularly where musculoskeletal pain, tension, or sleep disturbance contribute to overall distress or quality of life, but they are not considered core interventions for anxiety or depressive disorders. Evidence from small randomized trials and systematic reviews suggests possible short-term improvements in anxiety or depressive symptoms with manual therapy, including chiropractic, yet these studies are generally low to moderate quality, often involve small samples, heterogeneous interventions, and high risk of bias, and they do not replace first-line treatments. Mainstream care for anxiety and depression centers on evidence-based psychotherapy (such as cognitive behavioral therapy and related modalities), pharmacologic treatments when indicated, and lifestyle or psychosocial interventions; chiropractic manipulation is, at most, considered an adjunctive option aimed at pain and functional improvement rather than a direct treatment for psychiatric disorders.

Papers listed for this claim:[21][22][23][24]

In their own wordsView sourceArchived copy

“Anxiety, depression, and mood swings”

Rule: Neb. Rev. Stat. § 38-805(1)

See every doc bro who says they can treat or advise on Depression

Julie Gurbacki is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Chronic Fatigue Syndrome.

Chronic Fatigue Syndrome

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Chronic Fatigue Syndrome”

Rule: Neb. Rev. Stat. § 38-805(1)

See every doc bro who says they can treat or advise on Chronic fatigue and fibromyalgia

Julie Gurbacki is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Fibromyalgia.

Fibromyalgia

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Fibromyalgia”

Rule: Neb. Rev. Stat. § 38-805(1)

See every doc bro who says they can treat or advise on Chronic fatigue and fibromyalgia

Julie Gurbacki is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Chronic fatigue or brain fog.

Chronic fatigue or brain fog

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Chronic fatigue or brain fog”

Rule: Neb. Rev. Stat. § 38-805(1)

See every doc bro who says they can treat or advise on Chronic fatigue and fibromyalgia

Julie Gurbacki is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Functional Medicine.

Functional Medicine

Supports

There is moderate-quality evidence that chiropractic spinal manipulative therapy is about as effective as other recommended therapies (such as standard medical care and physical therapy) for short‑term pain relief and small improvements in function in adults with chronic low back pain. Some randomized controlled trials show clinically meaningful reductions in pain and disability with structured courses of chiropractic spinal manipulation (around 12 sessions over 6 weeks) in chronic non‑specific low back pain, with benefits sustained up to 52 weeks. A Cochrane review and other systematic reviews indicate that for acute and subacute low back pain, combined chiropractic interventions can slightly improve pain and disability in the short and medium term compared with other treatments, though long‑term differences are minimal. Overall, high‑quality evidence supports chiropractic care as a reasonable option for musculoskeletal spinal pain (especially low back pain), broadly comparable to other conservative treatments.

Papers listed for this claim:[25][26][27][28]

In their own wordsView sourceArchived copy

“Functional Medicine”

Rule: Neb. Rev. Stat. § 38-805(1)

Julie Gurbacki is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Chronic inflammation.

Chronic inflammation

Supports

There is some limited clinical evidence that chiropractic spinal manipulation can influence certain inflammatory biomarkers, mainly in musculoskeletal pain populations. A randomized controlled trial of 12 weeks of chiropractic spinal adjustments in adults reported changes in neuroimmune-related biomarkers: increased IL-6 and BDNF, decreased TNF-α, cortisol, and IFN-γ compared with sham care, suggesting modulation of stress and inflammatory pathways. This provides proof-of-concept that chiropractic care can affect systemic inflammatory markers, but the study was single-center, pragmatic, and focused on physiologic endpoints rather than clinical outcomes. Other small trials and non-randomized studies in chronic low back pain show reductions in pro‑inflammatory cytokines such as TNF-α and IL-6 and normalization trends in CRP after short courses of spinal manipulative therapy, again in the context of mechanical back pain rather than generalized chronic inflammatory disease. The listed guidelines on clinical nutrition in inflammatory bowel disease, hypertension, parenteral nutrition, tension-type headache, and pericarditis indicate chronic inflammatory conditions are commonly managed with pharmacologic therapy (e.g., colchicine in pericarditis) and evidence-based lifestyle or nutrition interventions, not chiropractic care. None of these major guidelines recommend chiropractic treatment as a primary or disease-modifying therapy for chronic systemic inflammation, but their extensive focus on inflammation as a therapeutic target supports the general concept that modulating inflammation can be clinically important.

Contradicts

High-quality evidence directly supporting chiropractic treatment as an effective therapy for chronic systemic inflammatory diseases is lacking. Existing trials are small, often focused on short-term changes in cytokines or CRP, with heterogeneous designs and typically in patients with musculoskeletal pain, not in conditions like rheumatoid arthritis, inflammatory bowel disease, or systemic autoimmune disorders. A systematic review of spinal manipulation for non-musculoskeletal conditions concluded that evidence for effectiveness is inconclusive, which undermines broad claims that chiropractic care treats chronic inflammation as a systemic process. More recent randomized trials on spinal mobilization/manipulation in neck pain found no meaningful changes in immediate systemic neuroimmune responses (e.g., IL‑1β, TNF‑α) despite improvements in pain and range of motion, suggesting that clinical benefits for pain do not necessarily translate into robust systemic anti-inflammatory effects. Listed guidelines for inflammatory bowel disease, hypertension, parenteral nutrition, tension-type headache, and pericarditis do not mention chiropractic care as a recommended intervention, and instead emphasize pharmacologic treatments, dietary management, and other conventional modalities backed by large RCTs and systematic reviews. This omission in authoritative guidelines indicates that the evidence base for chiropractic as a treatment for chronic inflammation is considered weak or insufficient. Overall, the available data show at most modest biomarker changes without clear demonstration of long-term clinical benefit in chronic inflammatory diseases, so broad claims that chiropractic therapy treats “chronic inflammation” are not supported by high-quality evidence.

Mainstream view

Mainstream medical and scientific opinion is that chiropractic care is an evidence‑supported option primarily for certain musculoskeletal conditions (such as low back pain and some neck pain), where benefits relate to pain reduction and function, not systemic disease modification. For chronic inflammatory diseases, standard of care is guided by major professional guidelines that rely on pharmacologic agents (e.g., anti‑inflammatory drugs, immunomodulators, biologics), validated lifestyle interventions (diet, exercise, smoking cessation), and disease-specific approaches such as nutrition in inflammatory bowel disease, antihypertensive regimens in hypertension, or colchicine in pericarditis. These guidelines are developed using formal evidence grading systems like GRADE, emphasizing RCTs and systematic reviews as the basis for recommendations. Chiropractic treatment is not recognized in these guidelines as a disease-modifying therapy for chronic systemic inflammation. While some small studies suggest spinal manipulation can alter certain inflammatory mediators, the mainstream view is that current evidence is insufficient to recommend chiropractic care as a primary or proven treatment for chronic inflammation; it may be used adjunctively for musculoskeletal pain within its established indications, but not as a substitute for guideline-directed management of chronic inflammatory conditions.

Papers listed for this claim:[5][6][7][8][9][10][11][12][13][29][30][31]

In their own wordsView sourceArchived copy

“Chronic inflammation”

Rule: Neb. Rev. Stat. § 38-805(1)

Julie Gurbacki is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Pediatric concerns (chronic ear infections, constipation, food sensitivities).

Pediatric concerns (chronic ear infections, constipation, food sensitivities)

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Pediatric concerns (chronic ear infections, constipation, food sensitivities)”

Rule: Neb. Rev. Stat. § 38-805(1)

See every doc bro who says they can treat or advise on Ear infections

Julie Gurbacki is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure Skin issues (eczema, acne, rashes).

Skin issues (eczema, acne, rashes)

Supports

There is no high-quality evidence such as randomized controlled trials, systematic reviews, or formal guidelines showing that chiropractic treatment is an effective primary therapy for eczema, acne, or common inflammatory skin rashes. The available literature consists mainly of case reports and small observational studies suggesting possible improvement in pruritic or neurocutaneous conditions (for example, brachioradial pruritus or notalgia paresthetica) after spinal manipulation or combined chiropractic/manual therapies, but these are single-patient reports without controls and do not establish efficacy or causality. Broad reviews of complementary and alternative medicine for atopic dermatitis identify various modalities (herbal medicine, acupuncture, probiotics, etc.) but do not list chiropractic as a tested or recommended intervention, indicating a lack of robust clinical trial data supporting chiropractic for eczema or other skin diseases. Existing RCTs and guidelines relevant to eczema, acne, and rashes instead support dermatologic and medical treatments such as emollients, topical corticosteroids, immunomodulators, phototherapy, and other skin-directed therapies as effective approaches, underscoring that evidence-based management lies in conventional dermatology rather than chiropractic manipulation.

Contradicts

High-quality dermatology evidence and guidelines emphasize skin-directed therapies and systemic treatments rather than spinal manipulation or chiropractic care for eczema, acne, and most rashes, indirectly contradicting any claim that chiropractic is an evidence-based primary treatment for these conditions. Large randomized trials show benefit from daily emollient use to prevent pediatric atopic dermatitis, supporting barrier-focused skin care, not chiropractic intervention. Other RCTs demonstrate the efficacy of topical agents (corticosteroids, sulfur preparations, palmitoylethanolamide, etc.) and procedures such as fractional CO2 laser plus topical steroids for eczema, again with no role for chiropractic care. Infant massage trials show benefit for infantile eczema but involve parent-performed skin massage rather than spinal manipulation, and are framed as adjuncts to routine dermatologic care. Systematic and guideline-based management of inflammatory conditions in other organ systems (e.g., inflammatory bowel disease, hypertension) relies on pharmacologic and lifestyle interventions, not chiropractic manipulation, illustrating that guideline-driven care generally does not consider chiropractic a treatment modality for systemic inflammatory or immune-mediated disease. Furthermore, the GRADE framework for rating evidence quality emphasizes that single case reports and uncontrolled series provide very low-certainty evidence, meaning the existing chiropractic case reports for skin conditions cannot support strong claims of efficacy.

Mainstream view

The mainstream medical and dermatologic position is that chiropractic care is not an established or recommended treatment for eczema, acne, or typical inflammatory skin rashes. Standard care for these conditions is based on well-studied dermatologic interventions: skin barrier optimization with emollients, topical corticosteroids and other anti-inflammatory agents, phototherapy for moderate-to-severe atopic eczema, systemic therapies for severe or refractory disease, and psychosocial or behavioral support where relevant. Complementary and alternative therapies may be considered adjunctive when supported by some evidence (for example, certain forms of acupuncture for itch reduction), but they are not substitutes for guideline-based dermatologic management, and chiropractic is generally not included among recommended modalities in dermatology guidelines or major reviews. Overall, chiropractic may sometimes be used for musculoskeletal pain or specific neurologically mediated pruritus syndromes, but it is not viewed as an evidence-based treatment for primary skin diseases such as eczema or acne.

Papers listed for this claim:[5][6][7][8][9][10][11][12][32][33][34][35]

In their own wordsView sourceArchived copy

“Skin issues (eczema, acne, rashes)”

Rule: Neb. Rev. Stat. § 38-805(1)

See every doc bro who says they can treat or advise on Skin conditions

Julie Gurbacki is not licensed or approved by Nebraska Board of Chiropractic to diagnose, treat, or cure FDA-approved therapy for Acne vulgaris.

FDA-approved therapy for Acne vulgaris

Supports

There is no high-quality evidence that chiropractic treatment is an FDA‑approved therapy for acne vulgaris, nor that it is an established evidence‑based treatment for acne in any major guideline or randomized trial. Current evidence and guidelines show that FDA‑approved and evidence‑based therapies for acne vulgaris are pharmacologic (topical retinoids, benzoyl peroxide, topical and systemic antibiotics, hormonal therapies, oral isotretinoin, etc.) and certain device‑based treatments (e.g., lasers, photodynamic therapy), not chiropractic manipulation.

Contradicts

Major acne guidelines and regulatory documents specify that effective and FDA‑approved therapies for acne vulgaris are drugs (topical retinoids, benzoyl peroxide, antibiotics, hormonal agents, oral isotretinoin) and, in some cases, physical modalities such as lasers or photodynamic therapy; none list chiropractic care or spinal manipulation as a treatment for acne. The FDA guidance on establishing effectiveness of drugs for acne vulgaris describes only pharmacologic interventions evaluated in randomized, double‑blind, placebo‑controlled trials and does not include chiropractic interventions. Dermatology guidelines from professional societies (e.g., American Academy of Dermatology, NICE) likewise do not mention chiropractic care in any role for acne management, either as primary or adjunctive therapy. Multiple randomized trials and systematic evidence reviews of acne therapies focus on medications, light/laser therapies, photodynamic therapy, and complementary approaches like acupuncture, but not chiropractic manipulation, further underscoring the absence of evidence for chiropractic as an acne treatment.

Mainstream view

The mainstream medical and scientific view is that acne vulgaris should be treated with evidence‑based dermatologic therapies: first‑line topical agents (retinoids, benzoyl peroxide, fixed‑dose combinations), short courses of systemic antibiotics when indicated, hormonal therapies in appropriate patients, and oral isotretinoin for severe, scarring, or treatment‑resistant disease. FDA‑approved therapies for acne are drugs and selected device‑based treatments that have demonstrated efficacy in properly designed clinical trials; chiropractic care is not recognized by the FDA or major dermatology guidelines as a therapy for acne vulgaris and is not considered part of standard or guideline‑driven management.

Papers listed for this claim:[5][6][7][9][8][10][11][12][36][37][38][39]

In their own wordsView sourceArchived copy

“FDA-approved therapy for Acne vulgaris”

Rule: Neb. Rev. Stat. § 38-805(1)

See every doc bro who says they can treat or advise on Skin conditions